SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Challenges and opportunities of drug repositioning · Study

ReviewChallenges and opportunities of drug repositioning

Natalia Novac2013

Review2013

Challenges and opportunities of drug repositioning

375 citations·0/0 files stored·Trends in Pharmacological Sciences

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Pharmaceutical Economics and Policy Computational Drug Discovery Methods Pharmaceutical studies and practices

Abstract

No abstract was published for this record.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 375 citations exist upstream.

References

2010How to improve R&D productivity: the pharmaceutical industry's grand challenge 2010Trends in Risks Associated With New Drug Development: Success Rates for Investigational Drugs

Cited by

2022Drug repurposing: a systematic review on root causes, barriers and facilitators 2020On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients

Related works

Explore the map →

Papers that cite the same references — the relational fallback while embeddings are still backfilling.

2021How Much Does It Cost to Research and Develop a New Drug? A Systematic Review and Assessmentreview · 2 shared references 2016Changing R&D models in research-based pharmaceutical companiesreview · 2 shared references 2017Drug discovery effectiveness from the standpoint of therapeutic mechanisms and indicationsreview · 2 shared references 2021Approval success rates of drug candidates based on target, action, modality, application, and their combinationsarticle · 2 shared references 2014Medicines for the Mind: Policy-Based “Pull” Incentives for Creating Breakthrough CNS Drugsreview · 2 shared references 2023Rival Signals and Project Selection: Insights from the Drug Development Processarticle · 2 shared references

Details

Year2013

Typereview

Published2013-04-16

VenueTrends in Pharmacological Sciences

ISSN-L0165-6147

Languageen

Citations375

Files0 public / 0

ShelfPharmaceutical Economics and Policy

Identifiers

doi10.1016/j.tips.2013.03.004

openalex_workW1968217711

Links

Imported from OpenAlex (CC0) — nothing here is generated.